<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 232 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page231.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=232">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 232 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 232</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=232"><img src="../thumb/232.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>196 / 2020-04                                                  Dermatologicals - 14.6 / 14.7 / 14.8 / 14.9

                                                                 WITH ALDARA YOUR PATIENTS
                                                                 HAVE EFFECTIVE SUSTAINED
                                   ACTINIC /    SUPERFICIAL    EXTERNAL
                                    SOLAR    BASAL CELL    GENITAL   CLEARANCE FOR AK, sBCC
                                   KERATOSIS  CARCINOMA  WARTS   AND EGW 1-4

   Side effects: Applicat.site burn./-prurit & site erythema, seborrh.,   ADCO-BIOHIST, AI Pharm Ltd [P/S]  EFUDIX, MEDA Pharma [P/S]
   acne, depigmentat., cheilit., applicat.site exfoliat./-pain/-dryness/-  Diphenhydramine HCl 10 mg, Zn oxide 50 mg, calamine 150 mg,   5-Fluorouracil
   discolourat./ -irrit./-paraesthes./-dermatit./-discomf./-oed./-vesicles/-  phenol 4 mg/ml.  Indications: Solar & senile keratos., Bowen’s dis., singl./multip.
   eczema/-warmth/-ulc., hypersens.,   Indications: Eczema, infect.skin sores, itch., insect bites, sun-  superfic.basal cell Ca, pre-malign. condits.
   Special precautions: Avoid eyes.& mucous membr., safety & effic.  burn, psorias.  (S4) OINT. D/13.8/122. 50 mg/g
   in childr.below 12 yrs.not est., worsen.of asthma report.  (S2) LOT. G2011.  722367-015: 20 g, R854,83
                                794120-008: 100 ml, R9,74     Dosage: Sen.& solar keratos: Apply to affect. areas 1-2x dly.
   SKINOREN GEL, (Adcock Ingram) Bayer [P/S] &  Dosage: Apply to affect.areas 3xdly.
   Azelaic acid.                Contra-indications: Ac.vesicul.& exudat.skin dis.  gen.without dress.
   Indications: Mild to mod.acne vulgar.& papulopustular rosacea.   Side-effects: Allerg.reacts., light sens.  Other condits: Apply occlus.dress.dly. Durat. usual. 3-4 wks. May
   (S1) GEL, 36/13.12/0028. 150 mg/g                          be exceed.if necess.
   703471-003: 30 g, R217,46    ALDARA, iNova [P/S] &         Contraindications: Pregn./susp.pregn.
   Dosage: Apply approx. 0,5 g(2,5 cm) 2xdly to affect.area aft.  Imiquimod  Side effects: Surround.skin redden.
   cleans. In case of irrit.reduc.amnt of gel/freq. Improvem.gen.ap-  Indications: Topic.treatm.of superfic.basal cell Ca, extern.genit./  Special precautions: Use und.strict med. supervis., max.skin area
                                                                           2
   parent within 4 wks.         perianal.warts (Condyloma acuminata), non hyperkeratotic, nonhy-  for treatm.not to exceed 500 cm , treat large areas in sect., avoid mu-
   Side effects: Contact.dermatit., applic.site prurit./ burn./pain/dryn./  pertrophic actin.keratos.(AKs) of face or scalp in adults.  cous membr & eyes, must wash hands aft.use.
   rash/paraesthes./erythema./ exfoliat./ warmth/discolourat., photos-  (S4) CREAM, 32/34/0541. 12,5 mg/sachet  ELIDEL, MEDA Pharma [P/S]
   ens.reacts., skin rash, fac.oed.  851884-008: 12 sngl.use sachets, R1 096,35  Pimecrolimus
   Special precautions: Safety in pregn.& lactat. not est., avoid eyes   722706-001: 1 pump (4 actuat.=1 sach), R730,91
   & muc.membr.., avoid alcohol. cleans./tinct.& astring./abras.& peel.  Dosage: Wash & dry area bef.applicat. Apply prior to sleep.& allow   Indications: Mild to mod.atopic dematit.in childr. 2-11 yrs/ado-
                                                              lesc.12-17 yrs.& adults for short term treatm.of signs and sympts.&
   agents.in papulopustul.rosacea, safety & effic.in childr.und. 12 yrs.  skin contact x8-(6-10) hrs. Apply thin layer & rub onto affect.area. Oc-
   for acne & und.18 yrs.for papulopustul. rosacea not est., worsen.of   clus. dressing not recomm. Wash off aft.rest period.  intermitt. ther.for prev.of progress of flares where alternat.convent.
   asthma report.post. market.  Superfic.basal cell Ca: Apply once dlyx5 consecut. days/wk.x6   ther.deem.inadvis./ respons. inadeq./intol.
   See also MDR page 254.       wks. Clinic.outcome determ. aft.treat.skin regenerates approx.6-12   (S4) CREAM, 36/34/0522. 10 mg/g
                                wks. aft. treatm.ends.        702081-002: 30 g, R393,96
   TETRALYSAL, Galderma Laboratories SA (Pty) Ltd  Extern.genit./Perianal warts: Apply once dly 3x/wk.(every oth-  702081-003: 60 g, R787,91
   See Section 18.4             er day follow.by a 2 day treatm. free interv) prior to norm.sleep.  Dosage: Adults and childr.2 yrs & over: Apply thin layer to affect.
   TRIPHASIL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  hrs. Keep on skin for 8-(6-10) hrs. Cont. treatm. till clear of warts   area 2xdly. May be applied to all skin areas incl.head,/face,/neck &
                                or for max.16 wks.
                                                              intertriginous areas. Apply on appear.of 1  S&S & resume on 1  recurr.
                                                                              st
                                                                                       st
   6 brown tabs: ethinyl oestradiol 30 µg, levonorgestrel 50 µg. 5 white
   tabs: ethinyl oestradiol 40 µg, levonorgestrel 75 µg. 10 yellow tabs:   Actinic Keratosis: Apply 3x/wk.prior to normal sleep. hrs.leave   of S&S if discont to prev. dis. flares. Due to low system.absorpt.tot.
                                in position x8 hrs,contin.x4 wks. If any AK’s persist.repeat treatm.
   ethinyl oestradiol 30 µg, levonorgestrel 125 µg. 7 red placebo tabs.  dly.dos. / surf.area treat/durat.of treatm.is not restrict. Emol.may be
   Indications: Fertil.contr.in women, dysfunct. uterine bleed.& prim.  for addit.4 wks. Max. total treatm.durat.8 wks. Assess treatm.aft   applied immed.aft.use, however aft. bath/show.apply emol.bef.Elidel
                                4 wk. treatm.free period. Sub-clinic.les.may appear in treatm.area.
   dysmenorrh.where contracept. desir., may benefit women on contra-  Side effects: V.common: Itch., burn.sensat., pain at wart treatm.  Contraindications: Childr.und.2 yrs., safety & effic. in pregn./
   cept.with coincident.acne.   site, erythema, eros., excoriat./ flak., oed., scabb., crust., myalg., ar-  lactat.& elderly not est., potent. malign./ pre-malign.skin les., act.
   (S3) TABS. N/18.8/40.        thralg., infect., pustules, naus., prurit./pain/burn./irritat./ erythema/   cutan.vir. infects.
   825832-004: 28, R68,48                                     Side effects: Infect.relat.lymphadenopathy, wart developm., skin/
   Dosage: 1 tab at same time dly, commenc.1st day menstr.cycle.  bleed./& pustules at applic.site. Common: Anorex. Uncommon:   subcutan.tiss.reacts., headache, nasopharyngit., influenza, pharyngit.,
                                Migraine, headache, fatig., influenza-like sympts., dermatit./ scar/
   Contraindications, Side effects, Special precautions, Drug   ulc./warmth & hyperaesthes.at applic.site, asthen., malaise. V.rare:   vir.  infect., pyrex., cough, herpeticum eczema, alcoh .intol., allerg.re-
   interactions: See sect.head note for oral contraceptives in Pharm.  ulcerat., indurat., vesicles,  acts.incl.rare anaphylax., resp. tract. infects., skin infects., otit.media,
   Class.in 17.1.1.             Warnings and special precautions: Safety & effic. in pts.und.18   rhinorrh., rhinit., wheez., GI disturbs., urticar., hypersens., applic.site
   ZINERYT, (Adcock Ingram) Astellas [P/S]  yrs.of age not est., auto-immune condits.exacerbat., organ transplant   reacts.incl.impetigo herpes
                                                              Special precautions: Long-term safety not est., rare cases of
   Erythromycin 40 mg, zinc acet.12 mg/ml  pts., consid. interrupt.dos.if intens.loc.inflamm.reacts. occur, assoc.   malign.report., treat.loc.clinic. infects. 1  incr varicella zoster/H
                                                                                st
   Indications: Mod.to sev.acne vulgaris  betw.complete clear.rate & loc.skin reacts. intens. which may be relat.  simplex vir. infect. risk theref.eval.risk vs.benef.in pres.of such
   (S4) TOP.LOT, 34/13.12/0474  to stimulat.of loc. immune respons., effic.decr.if too many dos. miss.   infects., investig.aetiology of lymphadenopathy which may have
   897783-007: 30 ml, R182,32   in AK treatm., skin noticeably diff.dur.AK ther. & until heal., protect   develop.& ensure it resolves, discont.in pres.of ac.infect. mono
                                                        st
   Dosage: Reconstit.accord.to direct.  treat.skin from solar expos., allow time for skin to recov.1  from any   nucleos./unclear aetiology of lymphadenopathy, not recomm.in
   Apply to skin of entire face 2xdly.x10-12 wks.  prev. med./surg.treatm., treat any infect that develops, wash skin   immunocompromis. pts., time to skin tumour format. in anim.
   Contraindications: Pregn.    bef.sex.activ., condoms & vag. diaphragms.poss.weaken., inflam-  photo-carcinogenic.study shortened theref.minim.or avoid nat./
   Side effects: Erythema, skin.burn.sensat., dry skin, prurit., skin ir-  mat.skin condits. poss.exacerbat., treatm.of ureth./intra-vag./ cervic./   artific. sunlight expos., concom.CYP3A inhibit., if S&S persist be-
   ritat./exfoliation, antibiot.cross-resist.organ.overgrowth, hypersens  rectal or intra-anal warts, not eval. for superfic.basal cell Ca within 1   yond 6 wks.re-exam.pt.to confirm diagnos., applicat.to vaccinat.
   Special precautions: In human exper.oral erythromyc.poss.causes   cm of eyelids/ nose/ lips, no exper.in immunocomprom.pts., hypo-/
   congenit.malformat., avoid eyes, nose & other muc.membr., concom.  hyperpigmentat.report., not recomm.in pregn.& lactat., Also pump:   sites not recomm., do not mix.with other top.meds., incr.S/E incid.
                                                              report. when topic.corticoster.used sequent., Netherton’s syndr.due
   top.acne ther., poss.mutual cross allerg.betw.macrolides.  Discard pump 4 wks.aft.open.
                                Interactions: Caut.with concom. immunosuppress. ther.  to incr.system.absorpt. potent.
                                See also MDR page 389.        HISTODOR, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   14.7   Melanin inhibitors and   ALLERGEX MEPYRAMINE CREAM, AI Pharm [P/S]  Mepyram.mal.50 mg, diphenhydram.HCl 50 mg/5 g.
                                Mepyramine maleate.
                                                              Indications: Allerg.& prurit.skin condit., insect bites & stings.
          stimulants            Indications: Allerg.& prurit.skin condits.  (S2) CREAM. G1756.
                                                              731269-004: 20 g, R15,08
                                (S2) CREAM. G1540. 2 g/100 g.
          No products listed    800511-018: 25 g, R12,62      Dosage: Apply to affect.area 2-3xdly.
                                Dosage: Apply to affect. area 3-4xdly.  Contra indications: Eczema.
   14.8   Emolients and protectives  Contraindications: Ac.vesicul.& exudat. dermat.  Side effects: Skin sensitisat., dermatit., system.S/E aft.applicat.
                                Side effects: Skin sensitisat.with eczemat. erupt., poss.system.
                                                              to large skin areas.
                                eff.if large areas treat.
   E45 CREAM, Reckitt Benckiser [P/S]  CALASTHETIC, AI Pharm Ltd [P/S]  INTRASITE APPLIPAK, Smith Nephew Pharm [P/S] &
                                                              Na Carboxymethyl cellulose.
   White soft paraff. 14,5 g, light liq.paraff. 12,6 g, anhydr.lanolin   Calamine 1,22 g, benzocaine 279,4 mg, phenol 25,3 mg, pheniramine
   (woolfat) 1 g/100 g.         mal. 10,2 mg/10 g.            Indications: Dress.for cavity wounds, extravasat. injur., ven.&
   Indications: Moisturise & relieves dry skin cond. for 48 hrs.  Indications: Sunburn, prurit., itch.skin condits.  decubit.ulc.
   (S0) CREAM. G1686.           (S2) CREAM. G1796.            (S0) GEL, 30/14.2/0117.
   725412-003: 50 g, R35,85     711624-003: 35 g, R41,18      894664-018: 0,345 g/unit, 10 x 15 g units, R1 041,66
   725415-046: 125°g, R61,24    Dosage: Apply 3-4xdly as reqd.  835323-021: 0,575 g/unit, 10 x 25 g units, R1 302,03
   725412-038: 500 g, R141,45   Contraindications: Ac.vesicul.& exudat. dermatos., infts.  Dosage: Prepare wound & using asept.techniq. introd. gel into
   Dosage: Apply as reqd.       Side effects: Allerg.reacts./skin sensitisat.with rep. applic., syst.effs.  wound, smooth over wound surface to minimum depth of 5 mm.
   Also avail in: Lotion        Special precautions: Do not appl.near eyes/ large skin areas.  Cover with second. dress. Change dress.when necess., gel should
                                                              not be left in wound for longer than 3 days.
                                DUOFILM, GSK [P/S]            Contraindications: Extern.use only, expos. musc. tendon/ bone,
   14.9   Others                Salicylic acid 16,7 g, lactic acid 15,03 g/100 g.  deep part.& full thickn.burns.
                                Indications: Plantar & mosaic warts.
                                                              Side effects: Trans.discomf/irrit.
          (See also 4.3)        LIQ, S/13.8/82.               Special precautions: Treat wounds with signs of clinic. in-
                                828750-009: 15 ml, R64,05.
                                                              fect.appropr.bef.use, seek medic.advice bef. using on wound
   ALDARA (MDR Listing)         Dosage: Apply 1-2 x dly.until cleared.  at high risk of infect., ulc. caus. by arter.insuffic.should be in-
   INTRASITE (MDR Listing)      Contraindications: Applic.to normal skin, face, ano-genit region.  spect.reg.by dr.
   IRUXOL (MDR Listing)         Side effects: Skin irrit., dermatit.  See also MDR page 688.
     References: 1. Krawtchenko N, et al. Br J Dermatol 2007; 157(Suppl.2):34-40. 2. Stockfleth E et al. Arch Dermatol/Vol 140, Dec 2004:1542. 3. Gollnick H, et al. Eur J Dermatol 2005; 15(5):374-381. 4. Edwards L, et al. Arch Dermatol 1998; 134:25-30.
     Scheduling status: S4 Proprietary name and dosage form: ALDARA Cream. Composition: Each 2,0 g cream pump contains 5 % Imiquimod (100 mg). ALDARA Cream Sachet. Composition: Each 250 mg cream sachet
     contains 5 % Imiquimod (12,5 mg). Preservatives: Methyl hydroxybenzoate 0.2 % m/m, Propyl hydroxybenzoate 0.02 % m/m, Benzyl alcohol 2 % m/m. Pharmacological classification: A 34 Other. Indications: ALDARA
     Cream is indicated for the topical treatment of superficial basal cell carcinoma (sBCC), and of external genital/perianal warts (condyloma acuminata) and clinically typical, non hyperkeratotic, nonhypertrophic actinic keratosis
     (AKs) on the face or scalp in adult patients. Registration number: 32/34/0541. Name and business address of the holder of the certificate of registration: iNova Pharmaceuticals (Pty) Ltd,. Co. Reg. No. 1952/001640/07,
     15e Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za. For full prescribing information, refer to the package insert as approved by the SAHPRA (South African Health Products Regulatory Authority).
     Further information is available on request from iNova Pharmaceuticals. IN3635/20</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page231.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page227.html">227</a>&nbsp;&nbsp;&nbsp;<a href="page228.html">228</a>&nbsp;&nbsp;&nbsp;<a href="page229.html">229</a>&nbsp;&nbsp;&nbsp;<a href="page230.html">230</a>&nbsp;&nbsp;&nbsp;<a href="page231.html">231</a>&nbsp;&nbsp;&nbsp;<a href="page232.html">232</a>&nbsp;&nbsp;&nbsp;<a href="page233.html">233</a>&nbsp;&nbsp;&nbsp;<a href="page234.html">234</a>&nbsp;&nbsp;&nbsp;<a href="page235.html">235</a>&nbsp;&nbsp;&nbsp;<a href="page236.html">236</a>&nbsp;&nbsp;&nbsp;<a href="page237.html">237</a>
             </td>
             <td width="35%"><a href="page233.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page233.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
